About Dr. Mark Levin
After earning his medical degree at the State University of New York Health Science Center in Brooklyn, Dr. Mark Levin has served for over 30 years as an administrator, clinician, researcher, and author in hematology and oncology.
Using his extensive experience in breast cancer, neuro-oncology, genitourinary oncology, and Gaucher disease, he has fulfilled the role of Director or Chief at four different university hospitals and cancer centers, including New Jersey Medical School and Weil-Cornell College of Medicine.
Dr. Levin has held the following positions over the past two decades:
- Interim Chief of Hematology and Oncology – New Jersey Medical School
- Cancer Center Director – Holy Name Hospital in Teaneck, NJ
- Chief of Hematology and Oncology and Chief of Service – Lincoln Medical Center
- Co-Director of Oncology – Brookdale University Hospital and Medical Center
- Affiliated with NYC Health + Hospitals Corporation
He is certified in Internal Medicine and Medical Oncology, obtained the Hematology certification, has an MBA and Board Certification in Quality Assurance and Utilization review, and has medical legal experience.
Dr. Levin completed residencies with New York University Downtown Hospital and the Drexel University Hahnemann University Hospital. He also completed his fellowship with the North Shore-Long Island Jewish Health System.
He is the first author of over 30 academic articles, chapters, and books on various hematology and oncology topics. Adding to his experience are his developing and running of two clinical research programs, a non-profit educational institution, and a consulting group.
Dr. Levin is well-versed in mesothelioma, having advised many mesothelioma patients and their families. With Mesothelioma Hope, he will contribute his knowledge and share his expertise about this deadly cancer.